The scrip was listed at Rs 171, at a premium of 90% to the issue price. The scrip hit a high of Rs 179.55 and a low of Rs 171. About 6.77 lakh shares of the company changed hands at the counter.
The initial public offer (IPO) of Hemant Surgicals received was subscribed 139.70 times. The issue opened for bidding on 24 May 2023 and it closed on 26 May 2023. The IPO price band was Rs 85 - Rs 90 per share.
The company intends to utilize the net proceeds for funding capital expenditure towards installation of additional plant and machinery, funding to meet working capital requirements, and general corporate purpose.
Hemant Surgical Industries manufactures, imports, assembles, and markets a comprehensive portfolio of medical equipments and disposables. The company's product offerings cover a wide spectrum of equipments and disposables required for renal care, cardiovascular disease, respiratory disease, critical care and radiology, and surgical disposables. The company also provides services for maintenance and running of dialysis centers. The company has a diversified product portfolio that caters to a widespread customer base across India and in international locations like Philippines, Bangladesh, Kenya, Bhutan, Burundi, Camaroon, Congo, Nepal, Nigeria, Ivory Coast, France, Seychelles, etc.
As on 31 December 2022, the company had approximately 172 employees at various levels.
The company recorded a revenue from operations of Rs 109.14 crore and net profit of Rs 7.65 crore for the financial year ended 31 March 2023.